Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.
We haven't written up this one. TechCrunch has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.